| Speaker* | Disclosures |
|---|---|
| Lisa Bero |
No funding for this presentation.
|
| Patricia Valdez | No relationships to disclose. |
| Daniel Greenbaum |
Full-time employee of the Health Effects Institute, a 501c3 nonprofit research institute. HEI’s funds, from which their compensation is drawn, come from
|
All sponsors of HEI provide input—along with the science and environmental communities—into priority topics HEI should address. Sponsors have no role, however, in selecting teams to conduct research, overseeing the implementation of that research, or reviewing the results of research prior to publication. |
|
| Clive Green | No relationships to disclose. |
| David Michaels |
Salary:
|
| Adrian Hernandez | Research American Regent; Amgen; Bayer; Boehringer Ingelheim; Merck; NIH: NIA, NCATS, NCCIH, NHLBI; Novartis; PCORI; Verily Consulting AstraZeneca; Biofourmis; Boston Scientific; Bristol Myers Squibb; Cytokinetics; Eidos Therapeutics; Intercept; Novartis; Novo Nordisk Editorial AMA: JAMA Cardiology |
| Laura Schmidt | No relationships to disclose. |
| Martin McKee |
|
| Adam Dunn |
|
| Dean Schillinger |
|
| Sunita Sah | No conflicts of interest to declare. |
| Rita Redberg |
No financial conflicts. Speaker’s comments today are as an individual; they are not speaking for the JAMA Network.
|
| Quinn Grundy |
No conflicts of interest to disclose.
|
| Vincent Cogliano | The presenter’s only professional compensation is from the State of California, but this presentation was developed outside of official time. The principles and processes discussed in this presentation were developed as part of the presenter’s previous employment at the International Agency for Research on Cancer (IARC). |
| Craig Umscheid |
|
*Panelist members who did not give an individual presentation did not report any disclosures.